Nuvation Bio, Inc. (NUVB)
5.14
-0.42
(-7.55%)
USD |
NYSE |
Oct 02, 16:00
5.17
+0.03
(+0.58%)
Pre-Market: 20:00
Nuvation Bio Profit Margin (Quarterly) : -198.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -198.3% |
| March 31, 2026 | 6.48% |
| December 31, 2025 | -87.40% |
| September 30, 2025 | -425.2% |
| June 30, 2025 | -1.22K% |
| Date | Value |
|---|---|
| March 31, 2025 | -1.73K% |
| December 31, 2024 | -865.8% |
| September 30, 2024 | -5.67K% |
| June 30, 2024 | -32.23K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 25.54% |
| Johnson & Johnson | 21.86% |
| Pfizer Inc. | -1.64% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.48% |
| Return on Assets | -23.42% |
| Return on Invested Capital | -26.42% |
| Gross Profit Margin (Quarterly) | 68.42% |
| Operating Margin (Quarterly) | -161.1% |
| Return on Net Operating Assets | -314.0% |